{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:37:31Z","timestamp":1777869451902,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neuroscience.2026.02.033","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:20:59Z","timestamp":1771950059000},"page":"112-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exenatide attenuates neuroinflammation and rescues sepsis-induced depressive behavior and cognitive dysfunction in a mouse model"],"prefix":"10.1016","volume":"600","author":[{"given":"Shenhai","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.02.033_b0010","doi-asserted-by":"crossref","unstructured":"Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet. 2017 Oct 7;390(10103):1664-1675. doi: 10.1016\/S0140-6736(17)31585-4. Epub 2017 Aug 3. PMID: 28781108; PMCID: PMC5831666.","DOI":"10.1016\/S0140-6736(17)31585-4"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.02.033_b0015","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI68295","article-title":"Exenatide and the treatment of patients with Parkinson's disease","volume":"123","author":"Aviles-Olmos","year":"2013","journal-title":"J Clin Invest."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.033_b0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JPD-140364","article-title":"Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease","volume":"4","author":"Aviles-Olmos","year":"2014","journal-title":"J Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.033_b0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00395-019-0743-0","article-title":"DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3\/ASC inflammasome","volume":"114","author":"Birnbaum","year":"2019","journal-title":"Basic Res Cardiol."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0030","doi-asserted-by":"crossref","unstructured":"Bock A. Study Reveals Nearly 300 New Depression Risk Factors Thanks to Wider Population Sample. JAMA. 2025 Feb 14. doi: 10.1001\/jama.2025.0251. Epub ahead of print. PMID: 39951319.","DOI":"10.1001\/jama.2025.0251"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.033_b0035","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1038\/cddis.2013.139","article-title":"Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals","volume":"4","author":"Bomba","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neurobiolaging.2017.12.009","article-title":"Exenatide exerts cognitive effects by modulating the BDNF-TrkB neurotrophic axis in adult mice","volume":"64","author":"Bomba","year":"2018","journal-title":"Neurobiol Aging."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.033_b0045","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.02.033_b0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jama.2024.25872","article-title":"Obesity and Glucagon-Like Peptide-1 Receptor Agonists","volume":"333","author":"Celletti","year":"2025","journal-title":"JAMA."},{"issue":"2025","key":"10.1016\/j.neuroscience.2026.02.033_b0060","article-title":"Trends in Prevalent Cases and Disability-Adjusted Life-Years of Depressive Disorders Worldwide: Findings From the Global Burden of Disease Study From 1990 to 2021","volume":"24","author":"Chen","year":"2025","journal-title":"Depress Anxiety."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.02.033_b0070","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol Metab."},{"issue":"20","key":"10.1016\/j.neuroscience.2026.02.033_b0075","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1056\/NEJMp2310181","article-title":"Depression - Advanced Treatments for Treatment-Resistant Depression","volume":"390","author":"Cristancho","year":"2024","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.033_b0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0090","doi-asserted-by":"crossref","unstructured":"De Camargo RW, Joaquim L, Machado RS, de Souza Ramos S, da Rosa LR, de Novais Junior LR, Mathias K, Maximiano L, Strickert YR, Nord R, Gava ML, Scarpari E, Martins HM, Lins EMF, Chaves JS, da Silva LE, de Oliveira MP, da Silva MR, Fernandes BB, Tiscoski ADB, Piacentini N, Santos FP, Inserra A, Bobinski F, Rezin GT, Yonamine M, Petronilho F, de Bitencourt RM. Ayahuasca Pretreatment Prevents Sepsis-Induced Anxiety-Like Behavior, Neuroinflammation, and Oxidative Stress, and Increases Brain-Derived Neurotrophic Factor. Mol Neurobiol. 2024 Nov 30. doi: 10.1007\/s12035-024-04597-4. Epub ahead of print. PMID: 39613951.","DOI":"10.1007\/s12035-024-04597-4"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.033_b0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41467-021-27760-0","article-title":"Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation","volume":"13","author":"Deganutti","year":"2022","journal-title":"Nat Commun."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.033_b0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat Med."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.02.033_b0105","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat Med."},{"issue":"18","key":"10.1016\/j.neuroscience.2026.02.033_b0110","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2147\/NDT.S273503","article-title":"Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions","volume":"16","author":"Elsayed","year":"2022","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.033_b0115","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cell.2022.12.033","article-title":"Neural mechanism underlying depressive-like state associated with social status loss","volume":"186","author":"Fan","year":"2023","journal-title":"Cell."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.02.033_b0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/iep.12255","article-title":"Glucose homeostasis in two degrees of sepsis lethality induced by caecum ligation and puncture in mice","volume":"98","author":"Ferreira","year":"2017","journal-title":"Int J Exp Pathol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.033_b0135","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/fcp.12192","article-title":"Exenatide enhances cognitive performance and upregulates neurotrophic factor gene expression levels in diabetic mice","volume":"30","author":"Gumuslu","year":"2016","journal-title":"Fundam Clin Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0140","doi-asserted-by":"crossref","unstructured":"Guo Q, Gobbo D, Zhao N, Zhang H, Awuku NO, Liu Q, Fang LP, Gampfer TM, Meyer MR, Zhao R, Bai X, Bian S, Scheller A, Kirchhoff F, Huang W. Adenosine triggers early astrocyte reactivity that provokes microglial responses and drives the pathogenesis of sepsis-associated encephalopathy in mice. Nat Commun. 2024 Jul 27;15(1):6340. doi: 10.1038\/s41467-024-50466-y. Erratum in: Nat Commun. 2024 Sep 18;15(1):8200. doi: 10.1038\/s41467-024-52497-x. PMID: 39068155; PMCID: PMC11283516.","DOI":"10.1038\/s41467-024-52497-x"},{"key":"10.1016\/j.neuroscience.2026.02.033_b0160","doi-asserted-by":"crossref","unstructured":"Krystal JH, Kaye AP, Jefferson S, Girgenti MJ, Wilkinson ST, Sanacora G, Esterlis I. Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments. Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2305772120. doi: 10.1073\/pnas.2305772120. Epub 2023 Nov 27. PMID: 38011560; PMCID: PMC10710048.","DOI":"10.1073\/pnas.2305772120"},{"issue":"445","key":"10.1016\/j.neuroscience.2026.02.033_b0165","article-title":"GLP-1 agonist Liraglutide prevents MK\u2011801-induced schizophrenia\u2011like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb\/c mice","volume":"8","author":"Kutlu","year":"2023","journal-title":"Behav Brain Res."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.033_b0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejps.2010.03.006","article-title":"Efficacy of a new sustained-release microsphere formulation of exenatide, DA-3091, in Zucker diabetic fatty (ZDF) rats","volume":"40","author":"Kwak","year":"2010","journal-title":"Eur J Pharm Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.033_b0175","doi-asserted-by":"crossref","first-page":"639","DOI":"10.36740\/WLek\/202719","article-title":"Depression in older adults","volume":"78","author":"Kwiatkowska","year":"2025","journal-title":"Wiad Lek."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0180","doi-asserted-by":"crossref","unstructured":"Lasselin J, Lekander M, Benson S, Schedlowski M, Engler H. Sick for science: experimental endotoxemia as a translational tool to develop and test new therapies for inflammation-associated depression. Mol Psychiatry. 2021 Aug;26(8):3672-3683. doi: 10.1038\/s41380-020-00869-2. Epub 2020 Sep 1. PMID: 32873895; PMCID: PMC8550942.","DOI":"10.1038\/s41380-020-00869-2"},{"issue":"303","key":"10.1016\/j.neuroscience.2026.02.033_b0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2015.06.054","article-title":"Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"10","author":"Liu","year":"2015","journal-title":"Neuroscience."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.02.033_b0190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fphar.2020.00136","article-title":"The Glucagon-Like Peptide-1 Analogue Liraglutide Reduces Seizures Susceptibility, Cognition Dysfunction and Neuronal Apoptosis in a Mouse Model of Dravet Syndrome","volume":"28","author":"Liu","year":"2020","journal-title":"Front Pharmacol."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.02.033_b0195","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","article-title":"Sucrose preference test for measurement of stress-induced anhedonia in mice","volume":"13","author":"Liu","year":"2018","journal-title":"Nat Protoc."},{"issue":"18","key":"10.1016\/j.neuroscience.2026.02.033_b0215","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev-clinpsy-072220-021440","article-title":"Major Depression and Its Recurrences: Life Course Matters","volume":"9","author":"Monroe","year":"2022","journal-title":"Annu Rev Clin Psychol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.033_b0225","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1186\/cc11674","article-title":"Mild hypoglycemia is independently associated with increased risk of mortality in patients with sepsis: a 3-year retrospective observational study","volume":"16","author":"Park","year":"2012","journal-title":"Crit Care."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0230","doi-asserted-by":"crossref","unstructured":"Qiu F, Zeng C, Liu Y, Pan H, Ke C. J147 ameliorates sepsis-induced depressive-like behaviors in mice by attenuating neuroinflammation through regulating the TLR4\/NF-\u03baB signaling pathway. J Mol Histol. 2023 Dec;54(6):725-738. doi: 10.1007\/s10735-023-10147-4. Epub 2023 Sep 7. PMID: 37676534; PMCID: PMC10635911.","DOI":"10.1007\/s10735-023-10147-4"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.033_b0235","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12410","article-title":"Melatonin administration to wild-type mice and nontreated NLRP3 mutant mice share similar inhibition of the inflammatory response during sepsis","volume":"63","author":"Rahim","year":"2017","journal-title":"J Pineal Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.033_b0240","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1038\/s41467-022-33867-9","article-title":"The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial","volume":"13","author":"Retnakaran","year":"2022","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.033_b0245","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41591-021-01584-3","article-title":"Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial","volume":"28","author":"Ruff","year":"2022","journal-title":"Nat Med."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0265","doi-asserted-by":"crossref","unstructured":"Shen CJ, Zheng D, Li KX, Yang JM, Pan HQ, Yu XD, Fu JY, Zhu Y, Sun QX, Tang MY, Zhang Y, Sun P, Xie Y, Duan S, Hu H, Li XM. Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior. Nat Med. 2019 Feb;25(2):337-349. doi: 10.1038\/s41591-018-0299-9. Epub 2019 Jan 14. Erratum in: Nat Med. 2019 Feb;25(2):350. doi: 10.1038\/s41591-019-0372-z. PMID: 30643290.","DOI":"10.1038\/s41591-018-0299-9"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.033_b0270","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bjc.12333","article-title":"Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis","volume":"61","author":"Shorey","year":"2022","journal-title":"Br J Clin Psychol."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0280","doi-asserted-by":"crossref","unstructured":"Simon GE, Moise N, Mohr DC. Management of Depression in Adults: A Review. JAMA. 2024 Jul 9;332(2):141-152. doi: 10.1001\/jama.2024.5756. Erratum in: JAMA. 2024 Oct 15;332(15):1306. doi: 10.1001\/jama.2024.18427. PMID: 38856993.","DOI":"10.1001\/jama.2024.5756"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.033_b0285","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.033_b0290","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047993","article-title":"Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study","volume":"11","author":"Vijiaratnam","year":"2021","journal-title":"BMJ Open."},{"issue":"10479","key":"10.1016\/j.neuroscience.2026.02.033_b0295","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(24)02808-3","article-title":"Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial","volume":"405","author":"Vijiaratnam","year":"2025","journal-title":"Lancet."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0300","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bbi.2024.10.033","article-title":"Running therapy or antidepressants as treatments for immunometabolic depression in patients with depressive and anxiety disorders: A secondary analysis of the MOTAR study","volume":"123","author":"Vreijling","year":"2025","journal-title":"Brain Behav Immun."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.033_b0305","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jointm.2022.12.002","article-title":"Recent advances in the study of sepsis-induced depression","volume":"3","author":"Wang","year":"2023","journal-title":"J Intensive Med."},{"issue":"1694","key":"10.1016\/j.neuroscience.2026.02.033_b0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2018.04.031","article-title":"Liraglutide attenuates the depressive- and anxiety-like behaviour in the corticosterone induced depression model via improving hippocampal neural plasticity","volume":"1","author":"Weina","year":"2018","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.033_b0315","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0320","doi-asserted-by":"crossref","unstructured":"Xie Y, Choi T, Al-Aly Z. Mapping the effectiveness and risks of GLP-1 receptor agonists. Nat Med. 2025 Mar;31(3):951-962. doi: 10.1038\/s41591-024-03412-w. Epub 2025 Jan 20. Erratum in: Nat Med. 2025 Mar;31(3):1038. doi: 10.1038\/s41591-025-03542-9. PMID: 39833406.","DOI":"10.1038\/s41591-025-03542-9"},{"issue":"7692","key":"10.1016\/j.neuroscience.2026.02.033_b0325","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature25509","article-title":"Ketamine blocks bursting in the lateral habenula to rapidly relieve depression","volume":"554","author":"Yang","year":"2018","journal-title":"Nature."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0330","doi-asserted-by":"crossref","unstructured":"Yang M, Silverman JL, Crawley JN. Automated three-chambered social approach task for mice. Curr Protoc Neurosci. 2011 Jul;Chapter 8:Unit 8.26. doi: 10.1002\/0471142301.ns0826s56. PMID: 21732314; PMCID: PMC4904775.","DOI":"10.1002\/0471142301.ns0826s56"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.033_b0335","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.immuni.2023.02.015","article-title":"STING activation in platelets aggravates septic thrombosis by enhancing platelet activation and granule secretion","volume":"56","author":"Yang","year":"2023","journal-title":"Immunity."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0340","first-page":"52587","article-title":"The forced swim test as a model of depressive-like behavior","volume":"97","author":"Yankelevitch-Yahav","year":"2015","journal-title":"J Vis Exp."},{"key":"10.1016\/j.neuroscience.2026.02.033_b0345","doi-asserted-by":"crossref","unstructured":"Yun SP, Kam TI, Panicker N, Kim S, Oh Y, Park JS, Kwon SH, Park YJ, Karuppagounder SS, Park H, Kim S, Oh N, Kim NA, Lee S, Brahmachari S, Mao X, Lee JH, Kumar M, An D, Kang SU, Lee Y, Lee KC, Na DH, Kim D, Lee SH, Roschke VV, Liddelow SA, Mari Z, Barres BA, Dawson VL, Lee S, Dawson TM, Ko HS. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease. Nat Med. 2018 Jul;24(7):931-938. doi: 10.1038\/s41591-018-0051-5. Epub 2018 Jun 11. PMID: 29892066; PMCID: PMC6039259.","DOI":"10.1038\/s41591-018-0051-5"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226001302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226001302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:48:53Z","timestamp":1777556933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226001302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":52,"alternative-id":["S0306452226001302"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.02.033","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exenatide attenuates neuroinflammation and rescues sepsis-induced depressive behavior and cognitive dysfunction in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}